Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HD vs GSK✓SelectedUSD · GSKHD vs GSK performance historyLatest closeAs of-0.34%11/16
Stock and ETF performance explorer

HD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+0.5%
GSK return
+46.9%
Excess return
-46.4%
Maximum drawdown
-34.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.3%-0.1%-0.3%-0.3%
7D-1.7%-1.3%-0.4%-1.4%
30D+12.2%+2.7%+9.5%+11.5%
3M+3.3%+2.7%+0.6%+2.6%
6M+18.5%+3.3%+15.2%+17.6%
YTD+3.2%+6.5%-3.3%+1.7%
1Y-1.4%+10.7%-12.0%-3.5%
3Y+22.5%+64.4%-41.9%+9.0%
5Y+0.5%+46.7%-46.2%-11.7%
All+0.5%+46.9%-46.4%-11.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling